Insider filing · RAPP
Steven M Paul
Director
profile →
Rapport Therapeutics, Inc.
RAPP · Healthcare · 38 filings in 24 months
ticker →
Steven M Paul bought $974K of Rapport Therapeutics (RAPP)
Executed Oct 22, disclosed Oct 22, the same day.
Value, as filed
$974K
35,714 sh × $27.28
Executed
Oct 22
the trade date, as filed
Disclosed
Oct 22
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
SPSteven M Paul (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $974K of RAPP (35,714 sh × $27.28, as filed), executed Oct 22. The median gap between execution and disclosure was 0 days.
The name
RAPPHealthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Steven M Paul in RAPP
RAPPPURCHASE
Rapport Therapeutics, Inc.
$1.0M41,666 sh across 2 lots
Exec Sep 12 2025
Filed Sep 15 2025 · 4:05 PM ET